Anteris Technologies Ltd (AVR.AX)
AUD 7.5
(-9.64%)
AUD 7.5
(-9.64%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -66.63 Million AUD | -51.26% |
| 2022 | -47.38 Million AUD | -105.96% |
| 2021 | -23 Million AUD | -21.24% |
| 2020 | -18.97 Million AUD | 26.18% |
| 2019 | -25.7 Million AUD | -10.5% |
| 2018 | -23.26 Million AUD | -32.61% |
| 2017 | -17.54 Million AUD | -32.38% |
| 2016 | -13.25 Million AUD | 55.51% |
| 2015 | -29.78 Million AUD | -18.85% |
| 2014 | -25.06 Million AUD | -71.18% |
| 2013 | -14.64 Million AUD | -242.98% |
| 2012 | -4.26 Million AUD | -322.7% |
| 2011 | 1.91 Million AUD | 129.73% |
| 2010 | 834.4 Thousand AUD | 156.87% |
| 2009 | -1.46 Million AUD | -15.78% |
| 2008 | -1.26 Million AUD | 1.4% |
| 2007 | -1.28 Million AUD | -357.92% |
| 2006 | -280.67 Thousand AUD | 67.81% |
| 2005 | -872.03 Thousand AUD | -520.26% |
| 2004 | 207.5 Thousand AUD | 129.01% |
| 2003 | -715.35 Thousand AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -52.35 Million AUD | 0.0% |
| 2023 Q4 | -40.68 Million AUD | 0.0% |
| 2023 Q2 | -30.98 Million AUD | 0.0% |
| 2023 FY | -71.67 Million AUD | -51.26% |
| 2022 Q4 | -24.69 Million AUD | 0.0% |
| 2022 Q2 | -22.69 Million AUD | 0.0% |
| 2022 FY | -47.38 Million AUD | -105.96% |
| 2021 FY | -23 Million AUD | -21.24% |
| 2021 Q2 | -9.84 Million AUD | 0.0% |
| 2021 Q4 | -13.16 Million AUD | 0.0% |
| 2020 Q2 | -10.11 Million AUD | 0.0% |
| 2020 Q4 | -8.86 Million AUD | 0.0% |
| 2020 FY | -18.97 Million AUD | 26.18% |
| 2019 Q2 | -13.42 Million AUD | 0.0% |
| 2019 Q4 | -13.06 Million AUD | 0.0% |
| 2019 FY | -25.7 Million AUD | -10.5% |
| 2018 Q4 | -12.12 Million AUD | 0.0% |
| 2018 FY | -23.26 Million AUD | -32.61% |
| 2018 Q2 | -11.14 Million AUD | 0.0% |
| 2017 FY | -17.54 Million AUD | -32.38% |
| 2017 Q2 | -9.04 Million AUD | 0.0% |
| 2016 Q2 | -13.89 Million AUD | 0.0% |
| 2016 Q4 | -6.97 Million AUD | 0.0% |
| 2016 FY | -13.25 Million AUD | 55.51% |
| 2015 Q4 | -15.89 Million AUD | 0.0% |
| 2015 FY | -29.78 Million AUD | -18.85% |
| 2015 Q2 | -13.79 Million AUD | 0.0% |
| 2014 FY | -25.06 Million AUD | -71.18% |
| 2014 Q2 | -10.4 Million AUD | 0.0% |
| 2014 Q4 | -11.26 Million AUD | 0.0% |
| 2013 FY | -14.64 Million AUD | -242.98% |
| 2013 Q4 | -4.23 Million AUD | 0.0% |
| 2013 Q2 | -2.83 Million AUD | 0.0% |
| 2012 Q2 | -2.53 Million AUD | 0.0% |
| 2012 Q1 | -2.53 Million AUD | 0.0% |
| 2012 FY | -4.26 Million AUD | -322.7% |
| 2012 Q4 | -1.58 Million AUD | 37.27% |
| 2012 Q3 | -2.53 Million AUD | 0.0% |
| 2011 Q2 | -489.41 Thousand AUD | 0.0% |
| 2011 Q3 | -489.41 Thousand AUD | 0.0% |
| 2011 Q4 | -2.53 Million AUD | -417.5% |
| 2011 FY | 1.91 Million AUD | 129.73% |
| 2011 Q1 | -489.41 Thousand AUD | 0.0% |
| 2010 FY | 834.4 Thousand AUD | 156.87% |
| 2010 Q3 | -327.91 Thousand AUD | 0.0% |
| 2010 Q4 | -489.41 Thousand AUD | -49.25% |
| 2010 Q2 | -327.91 Thousand AUD | 0.0% |
| 2010 Q1 | -327.91 Thousand AUD | 0.0% |
| 2009 Q3 | -295.72 Thousand AUD | 0.0% |
| 2009 Q4 | -327.91 Thousand AUD | -10.89% |
| 2009 Q2 | -295.72 Thousand AUD | 0.0% |
| 2009 FY | -1.46 Million AUD | -15.78% |
| 2009 Q1 | -295.72 Thousand AUD | 0.0% |
| 2008 Q3 | -335.23 Thousand AUD | 0.0% |
| 2008 FY | -1.26 Million AUD | 1.4% |
| 2008 Q4 | -295.72 Thousand AUD | 11.78% |
| 2008 Q2 | -335.23 Thousand AUD | 0.0% |
| 2008 Q1 | -335.23 Thousand AUD | 0.0% |
| 2007 Q1 | -662.41 Thousand AUD | 0.0% |
| 2007 Q4 | -335.23 Thousand AUD | 49.39% |
| 2007 FY | -1.28 Million AUD | -357.92% |
| 2007 Q3 | -662.41 Thousand AUD | 0.0% |
| 2007 Q2 | -662.41 Thousand AUD | 0.0% |
| 2006 Q3 | -277.86 Thousand AUD | 0.0% |
| 2006 Q4 | -662.41 Thousand AUD | -138.39% |
| 2006 FY | -280.67 Thousand AUD | 67.81% |
| 2006 Q1 | -277.86 Thousand AUD | 0.0% |
| 2006 Q2 | -277.86 Thousand AUD | 0.0% |
| 2005 Q4 | -277.86 Thousand AUD | 68.56% |
| 2005 FY | -872.03 Thousand AUD | -520.26% |
| 2005 Q1 | -883.88 Thousand AUD | 0.0% |
| 2005 Q2 | -883.88 Thousand AUD | 0.0% |
| 2005 Q3 | -883.88 Thousand AUD | 0.0% |
| 2004 Q3 | -178.83 Thousand AUD | 0.0% |
| 2004 FY | 207.5 Thousand AUD | 129.01% |
| 2004 Q2 | -178.83 Thousand AUD | 0.0% |
| 2004 Q4 | -883.88 Thousand AUD | -394.24% |
| 2004 Q1 | -178.83 Thousand AUD | 0.0% |
| 2003 FY | -715.35 Thousand AUD | 0.0% |
| 2003 Q4 | -178.83 Thousand AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| 4DMedical Limited | -27.96 Million AUD | -138.261% |
| Adherium Limited | -11.98 Million AUD | -455.953% |
| Aroa Biosurgery Limited | -9.78 Million AUD | -580.779% |
| Atomo Diagnostics Limited | -4.36 Million AUD | -1427.754% |
| Control Bionics Limited | -5.92 Million AUD | -1023.793% |
| CardieX Limited | -4.63 Million AUD | -1337.997% |
| Compumedics Limited | -269 Thousand AUD | -24670.503% |
| Cochlear Limited | 521.5 Million AUD | 112.777% |
| CleanSpace Holdings Limited | -4.81 Million AUD | -1284.153% |
| Cyclopharm Limited | -9.22 Million AUD | -622.331% |
| EMVision Medical Devices Ltd | -1.61 Million AUD | -4027.371% |
| Nova Eye Medical Limited | -3.79 Million AUD | -1654.876% |
| HeraMED Limited | -6.42 Million AUD | -936.602% |
| Imricor Medical Systems, Inc. | -17.57 Million AUD | -279.126% |
| ImpediMed Limited | -19.03 Million AUD | -250.035% |
| InhaleRx Limited | -1.38 Million AUD | -4705.862% |
| LBT Innovations Limited | -4.74 Million AUD | -1305.752% |
| Micro-X Limited | -13.02 Million AUD | -411.497% |
| Neurotech International Limited | -5.58 Million AUD | -1093.109% |
| OncoSil Medical Limited | -11.98 Million AUD | -456.004% |
| PolyNovo Limited | 1.16 Million AUD | 5829.377% |
| Respiri Limited | -7 Million AUD | -851.868% |
| SomnoMed Limited | -3.84 Million AUD | -1634.64% |
| Universal Biosensors, Inc. | -16.68 Million AUD | -299.469% |
| Uscom Limited | -2.4 Million AUD | -2671.339% |
| Visioneering Technologies, Inc. | -5.85 Million AUD | -1038.217% |